{
    "title": "'Very unattractive' Britain leaves drugmaker AstraZeneca eyeing China as the next big growth region",
    "url": "https://www.dailymail.co.uk/money/markets/article-12021691/Very-unattractive-Britain-leaves-drugmaker-AstraZeneca-eyeing-China-big-growth-region.html",
    "date": "2023-04-27",
    "keywords": [
        "cent",
        "soriot",
        "china",
        "group",
        "share",
        "account",
        "fund",
        "growth",
        "country",
        "manufacturing",
        "exec",
        "firm",
        "year",
        "revenue",
        "money",
        "diy",
        "investment",
        "fee",
        "boss",
        "drugmaker",
        "astrazeneca",
        "uk",
        "region",
        "executive",
        "britain",
        "britainthe",
        "britainsoriot",
        "explosion",
        "biotech",
        "pressure",
        "europe",
        "limitation",
        "yearonyear",
        "drop",
        "vaccine",
        "vaxzevria",
        "evusheld",
        "antibody",
        "treatment",
        "virus",
        "use",
        "authorisation",
        "virusbut",
        "jump",
        "cancer",
        "drug",
        "covid",
        "guidance",
        "percentage",
        "meeting",
        "challenge",
        "leadership",
        "shareholder",
        "pirc",
        "removal",
        "company",
        "brad",
        "end",
        "hissy",
        "fit",
        "setback",
        "cbi",
        "chief",
        "female",
        "giant",
        "row",
        "decision",
        "article",
        "capital",
        "risk",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}